Back to Agenda
Session 4
Session Chair(s)
Taiji Yamasaki
Senior Director, Study Management
Merck & Co., Inc., Japan
Kumiko Okada
Study Manager, Clinical Operations
Pfizer R&D, Japan
Speaker(s)
Keisuke Shimizu
Keisuke Shimizu
Lung Cancer HER2 “HER HER”, Japan
Yosuke Chiyomori
Yosuke Chiyomori
Eli Lilly Japan K.K., Japan
Clinical Development Manager, Trial Mgmt,Clinical Development Ops & Innovations
Hiroya Komoda
Hiroya Komoda
Pfizer R&D Japan, Japan
Clinical Project Manager, Clinical Project Management Group
Have an account?